dostęp otwarty
Plejotopowe działanie witaminy D


- I Katedra i Klinika Kardiologii Gdańskiego Uniwersytetu Medycznego
dostęp otwarty
Streszczenie
Streszczenie
Słowa kluczowe
witamina D; niedobór witaminy D; plejotropizm


Tytuł
Plejotopowe działanie witaminy D
Czasopismo
Numer
Strony
45-52
Wyświetlenia strony
1208
Wyświetlenia/pobrania artykułu
4383
DOI
10.5603/ChSiN.2019.0007
Rekord bibliograficzny
Choroby Serca i Naczyń 2019;16(1):45-52.
Słowa kluczowe
witamina D
niedobór witaminy D
plejotropizm
Autorzy
Marta Marcinkowska
Agnieszka Mickiewicz
Marcin Fijałkowski


- Anuszewska EL. Nowe spojrzenie na witaminę D. Gaz Farm. 2011; 2: 32–35.
- Płudowski P, Karczmarewicz E, Bayer M, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013; 64(4): 319–327.
- Pludowski P, Holick MF, Grant WB, et al. Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol. 2018; 175: 125–135.
- Piotrowska A, Wierzbicka J, Żmijewski MA. Vitamin D in the skin physiology and pathology. Acta Biochim Pol. 2016; 63(1): 17–29.
- Haussler MR, Jurutka PW, Mizwicki M, et al. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011; 25(4): 543–559.
- Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013; 12(10): 976–989.
- Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010; 9(11): 709–715.
- Garland CF, Kim JJ, Mohr SB, et al. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health. 2014; 104(8): e43–e50.
- Okuno H, Kishimoto KN, Hatori M, et al. 1α,25-dihydroxyvitamin D₃ enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts. Cell Biol Int. 2012; 36(5): 441–447.
- Peterson AL, Murchison C, Zabetian C, et al. Memory, mood, and vitamin D in persons with Parkinson's disease. J Parkinsons Dis. 2013; 3(4): 547–555.
- Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation. 1997; 96(6): 1755–1760.
- Juonala M, Voipio A, Pahkala K, et al. Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study. J Clin Endocrinol Metab. 2015; 100(4): 1469–1476.
- Singh RJ, Taylor RL, Reddy GS, et al. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006; 91(8): 3055–3061.
- Lensmeyer G, Poquette M, Wiebe D, et al. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J Clin Endocrinol Metab. 2012; 97(1): 163–168.
- Rusińska A, Płudowski P, Walczak M, et al. Vitamin D supplementation guidelines for general population and groups at risk of vitamin D deficiency in Poland — recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies — 2018 4pdate. Front Endocrinol (Lausanne). 2018; 9: 246.
- Kaufmann M, Morse N, Molloy BJ, et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med. 2011; 365(5): 410–421.
- Hilger J, Friedel A, Herr R, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr. 2014; 111(1): 23–45.
- Karczmarewicz E, Czekuc-Kryskiewicz E, Płudowski P. Effect of vitamin D status on pharmacological treatment efficiency: impact on cost-effective management in medicine. Dermatoendocrinol. 2013; 5(2): 299–304.
- Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008; 88(2): 491S–499S.
- Hollis BW, Wagner CL, Drezner MK, et al. Circulating vitamin D3 and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol. 2007; 103(3-5): 631–634.
- Wacker M, Holick MF. Sunlight and Vitamin D: a global perspective for health. Dermatoendocrinol. 2013; 5(1): 51–108.
- Mozołowski W. Jędrzej Sniadecki (1768–1838) on the cure of rickets. Nature. 1939; 143(3612): 121–121.
- Haddad JG, Matsuoka LY, Hollis BW, et al. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest. 1993; 91(6): 2552–2555.
- Grigalavicius M, Iani V, Juzeniene A. Layer thickness of SPF 30 sunscreen and formation of pre-vitamin D. Anticancer Res. 2016; 36(3): 1409–1415.
- Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266–281.
- Webb AR. Who, what, where and when-influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol. 2006; 92(1): 17–25.
- Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab. 1987; 64(6): 1165–1168.
- Stenberg C, Larkö O. Sunscreen application and its importance for the sun protection factor. Arch Dermatol. 1985; 121(11): 1400–1402.
- Bech-Thomsen N, Wulf HC. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed. 1992; 9(6): 242–244.
- Neale R, Williams G, Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch Dermatol. 2002; 138(10): 1319–1325.
- Szepietowski JC, Nowicka D, Reich A, et al. Application of sunscreen preparations among young Polish people. J Cosmet Dermatol. 2004; 3(2): 69–72.
- Reich A, Harupa M, Bury M, et al. Application of sunscreen preparations: a need to change the regulations. Photodermatol Photoimmunol Photomed. 2009; 25(5): 242–244.
- Petersen B, Datta P, Philipsen PA, et al. Sunscreen use and failure — on site observations on a sun-holiday. Photochem Photobiol Sci. 2013; 12(1): 190–196.
- Autier P, Boniol M, Severi G, et al. European Organizatin for Research and Treatment of Cancer Melanoma Co-operative Group. Quantity of sunscreen used by European students. Br J Dermatol. 2001; 144(2): 288–291.
- Diaz A, Neale RE, Kimlin MG, et al. The children and sunscreen study: a crossover trial investigating children's sunscreen application thickness and the influence of age and dispenser type. Arch Dermatol. 2012; 148(5): 606–612.